New Zealand - English - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - orciprenaline sulfate 0.225 g (per container, 0.75mg/dose) - aerosol inhaler, metered dose - 0.75 mg/dose - active: orciprenaline sulfate 0.225 g (per container, 0.75mg/dose) excipient: cryofluorane dichlorodifluoromethane phosphatidylcholines, soya, hydrogenated trichlorofluoromethane

Canada - English - Health Canada

apotex inc - orciprenaline sulfate - syrup - 2mg - orciprenaline sulfate 2mg - selective beta 2-adrenergic agonists

Canada - English - Health Canada

aa pharma inc - orciprenaline sulfate - syrup - 2mg - orciprenaline sulfate 2mg - selective beta 2-adrenergic agonists

Canada - English - Health Canada

ratiopharm inc division of teva canada limited - orciprenaline sulfate - syrup - 2mg - orciprenaline sulfate 2mg - selective beta 2-adrenergic agonists

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - salbutamol sulfate, quantity: 6 mg (equivalent: salbutamol, qty 5 mg) - inhalation, conventional - excipient ingredients: sulfuric acid; water for injections; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - salbutamol sulfate, quantity: 3 mg (equivalent: salbutamol, qty 2.5 mg) - inhalation, conventional - excipient ingredients: water for injections; sulfuric acid; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - indicated for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.